C
Bio-Techne Corporation TECH
$48.21 $0.841.77% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2026 12/31/2025 09/30/2025 06/30/2025 03/31/2025
Net Income -16.79% -48.71% -48.26% -56.34% -35.14%
Total Depreciation and Amortization -12.33% -6.65% -4.02% 1.22% -3.06%
Total Amortization of Deferred Charges -5.58% -5.58% -5.58% -5.58% 5.19%
Total Other Non-Cash Items 154.71% 127.14% 114.68% 216.74% 954.27%
Change in Net Operating Assets -16.18% -395.04% -16,199.25% 214.18% -88.69%
Cash from Operations 11.33% -18.18% -17.21% -3.82% -13.70%
Capital Expenditure 42.72% 47.84% 53.48% 50.69% 20.87%
Sale of Property, Plant, and Equipment 194.86% 194.86% -- -- --
Cash Acquisitions -- -- -- -- 100.00%
Divestitures -- -- -- -- --
Other Investing Activities 542.97% 316.74% 181.65% -122.41% -107.90%
Cash from Investing 75.84% 73.48% 81.74% 82.67% 77.69%
Total Debt Issued 73.68% -- 60.00% -53.78% -83.11%
Total Debt Repaid -102.06% 2.04% 49.27% 69.92% 52.91%
Issuance of Common Stock -5.88% -31.39% -30.02% -15.09% 47.47%
Repurchase of Common Stock 39.16% -156.87% -230.59% -176.95% -79.58%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 1.60% 1.48% 0.61% 0.06% -0.48%
Other Financing Activities -- -- -- -- --
Cash from Financing -1.26% -21.05% -39.45% -107.44% -158.36%
Foreign Exchange rate Adjustments 195.56% 344.39% -51.18% 611.23% 144.03%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 9,058.81% -109.85% -209.52% 136.12% -94.02%